首页 | 本学科首页   官方微博 | 高级检索  
     


PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions
Authors:Liliang Xia  Yuanyong Liu  Ying Wang
Affiliation:1. Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China

Contributed equally;2. Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China

School of Life Science and Technology, Changchun University of Science and Technology, Changchun, People's Republic of China

Contributed equally;3. Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China

Abstract:
Keywords:Immune checkpoint inhibitors  PD-1/PD-L1  Non-small-cell lung cancer  Clinical trials  Combination therapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号